Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OPSUMIT vs ORITAVANCIN DIPHOSPHATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OPSUMIT vs ORITAVANCIN DIPHOSPHATE: Safety Overview

Metric OPSUMIT ORITAVANCIN DIPHOSPHATE
Total FAERS Reports 339 276
Deaths Reported 64 4
Death Rate 18.9% 1.4%
Hospitalizations 117 27
Average Patient Age 65.1 yrs 58.5 yrs
% Female Patients N/A 39.2%
FDA Approval Date N/A Aug 6, 2014
Manufacturer N/A Melinta Therapeutics, LLC
Route N/A INTRAVENOUS
Marketing Status N/A Prescription